Multi-functionalized biologically active isatin-tagged dihydropyrimidine derivatives: green synthesis by the use of recyclable Fe-dopped Ce-oxide nanoparticles, computational studies and ex vivo cytotoxic activity against breast cancer cells
Abstract
A new class of compounds was designed and synthesised using a molecular hybridisation technique based on the dihydropyridine, isatin, triazole, thiazole, benzothiazole, and glucose scaffolds. The alkyne derivatives of dihydropyridine were synthesised by using reusable Fe-doped Ce-oxide nanoparticles via a three-component Biginelli reaction. The substances were then tested for their cytotoxic effects on two human breast tumour cell lines, MCF-7 and MDA-MB-231, as well as non-cancerous breast epithelial cell lines (i.e., HEK293). The primary objective was to synthesise the more efficient breast cancer cell inhibitory molecules, which contain multiple scaffolds, and to investigate their potential as anti-breast cancer cell inhibitory therapeutic agents. Notably, compound-6, 7 and 14a exhibited remarkable anti-cancer activity against two prominent breast-cancer cell-lines, MCF-7 and MDA-MB-231. The IC50 values of the compounds 6, 7, and 14a against MCF-7 and MDA-MB-231breast cancer cell lines were found to be the lowest. The successful synthesis of these dihyropyrimidines using an environmentally friendly approach emphasises the significance of sustainable and eco-friendly methodologies in pharmaceutical research.
How strong is the evidence?
Evidence Hub reads this as a simulation / modelling, done in cell cultures (in vitro), not in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- A Coupled SYSTEM of Intracellular Ca 2+ Clocks and Surface Membrane Voltage Clocks Controls the Timekeeping Mechanism of the Heart’s Pacemaker
- A Comprehensive Review on the Therapeutic Potential of Curcuma longa Linn. in Relation to its Major Active Constituent Curcumin
- Cancer epigenetics: Moving forward
- Current developments in LC-MS for pharmaceutical analysis
- Myricetin: A comprehensive review on its biological potentials
- A Computational Systems Biology Software Platform for Multiscale Modeling and Simulation: Integrating Whole-Body Physiology, Disease Biology, and Molecular Reaction Networks
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.